Cargando…
Relaxin—when a successful super-drug is failing
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492565/ https://www.ncbi.nlm.nih.gov/pubmed/35904637 http://dx.doi.org/10.1007/s00424-022-02734-3 |
| _version_ | 1784793511750533120 |
|---|---|
| author | Schlüter, Klaus-Dieter |
| author_facet | Schlüter, Klaus-Dieter |
| author_sort | Schlüter, Klaus-Dieter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9492565 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94925652022-09-23 Relaxin—when a successful super-drug is failing Schlüter, Klaus-Dieter Pflugers Arch Comment Springer Berlin Heidelberg 2022-07-29 2022 /pmc/articles/PMC9492565/ /pubmed/35904637 http://dx.doi.org/10.1007/s00424-022-02734-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Comment Schlüter, Klaus-Dieter Relaxin—when a successful super-drug is failing |
| title | Relaxin—when a successful super-drug is failing |
| title_full | Relaxin—when a successful super-drug is failing |
| title_fullStr | Relaxin—when a successful super-drug is failing |
| title_full_unstemmed | Relaxin—when a successful super-drug is failing |
| title_short | Relaxin—when a successful super-drug is failing |
| title_sort | relaxin—when a successful super-drug is failing |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492565/ https://www.ncbi.nlm.nih.gov/pubmed/35904637 http://dx.doi.org/10.1007/s00424-022-02734-3 |
| work_keys_str_mv | AT schluterklausdieter relaxinwhenasuccessfulsuperdrugisfailing |